U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06815432) titled 'GPC-3 CAR T CELLS for Recurrent GPC-3 Positive Glioblastoma' on Feb. 04.
Brief Summary: The body has different ways of fighting infection and disease. No single way seems perfect for fighting cancers. This research study combines two different ways of fighting cancer: antibodies and T cells.
Antibodies are types of proteins that protect the body from infectious diseases and possibly cancer. T-cells, also called T lymphocytes, are special infection-fighting blood cells that can kill other cells, including cells infected with viruses and tumor cells. Both antibodies and T cells have been used to treat participants with cancers. They h...